Posted May. 8, 2012 at 5:12 p.m.

Premium Lock Pozen migraine drug licensed to Desitin for commercialization in Europe

Published: 2012-05-08 17:12:10
Updated: 2012-05-08 17:12:10

Pozen The migraine headache treatment developed by Pozen now has a partner for commercialization in Europe.

The migraine headache treatment developed by Pozen now has a partner for commercialization in Europe....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll